Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

The Consumer Durables industry as a whole closed the day down 0.4% versus the S&P 500, which was down 0.5%. Laggards within the Consumer Durables industry included Kewaunee Scientific ( KEQU), down 4.7%, Koss ( KOSS), down 3.6%, Virco Manufacturing ( VIRC), down 1.9%, EveryWare Global ( EVRY), down 2.1% and Ballantyne Strong ( BTN), down 3.2%.

TheStreet Ratings Group would like to highlight 3 stocks that pushed the industry lower today:

EveryWare Global ( EVRY) is one of the companies that pushed the Consumer Durables industry lower today. EveryWare Global was down $0.02 (2.1%) to $0.93 on light volume. Throughout the day, 35,686 shares of EveryWare Global exchanged hands as compared to its average daily volume of 90,000 shares. The stock ranged in price between $0.89-$0.99 after having opened the day at $0.95 as compared to the previous trading day's close of $0.95.

EveryWare Global has a market cap of $22.8 million and is part of the consumer goods sector. Shares are up 30.1% year-to-date as of the close of trading on Tuesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

At the close, Virco Manufacturing ( VIRC) was down $0.05 (1.9%) to $2.53 on light volume. Throughout the day, 4,406 shares of Virco Manufacturing exchanged hands as compared to its average daily volume of 28,200 shares. The stock ranged in price between $2.50-$2.54 after having opened the day at $2.50 as compared to the previous trading day's close of $2.58.

Virco Mfg. Corporation is engaged in the design, production, and distribution of furniture for the commercial and education markets in the United States. Virco Manufacturing has a market cap of $34.9 million and is part of the consumer goods sector. Shares are up 5.7% year-to-date as of the close of trading on Tuesday. Currently there are no analysts who rate Virco Manufacturing a buy, no analysts rate it a sell, and 1 rates it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates Virco Manufacturing as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth and good cash flow from operations. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year.

Highlights from TheStreet Ratings analysis on VIRC go as follows:

  • VIRC's revenue growth has slightly outpaced the industry average of 3.0%. Since the same quarter one year prior, revenues slightly increased by 5.4%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
  • VIRCO MFG. CORP has improved earnings per share by 34.8% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. This trend suggests that the performance of the business is improving. During the past fiscal year, VIRCO MFG. CORP continued to lose money by earning -$0.13 versus -$0.27 in the prior year. This year, the market expects an improvement in earnings (-$0.02 versus -$0.13).
  • VIRC's debt-to-equity ratio is very low at 0.23 and is currently below that of the industry average, implying that there has been very successful management of debt levels. Although the company had a strong debt-to-equity ratio, its quick ratio of 0.71 is somewhat weak and could be cause for future problems.
  • The company, on the basis of net income growth from the same quarter one year ago, has significantly underperformed compared to the Commercial Services & Supplies industry average, but is greater than that of the S&P 500. The net income increased by 35.9% when compared to the same quarter one year prior, rising from $3.41 million to $4.63 million.
  • VIRC has underperformed the S&P 500 Index, declining 7.34% from its price level of one year ago. The fact that the stock is now selling for less than others in its industry in relation to its current earnings is not reason enough to justify a buy rating at this time.

You can view the full analysis from the report here: Virco Manufacturing Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Kewaunee Scientific ( KEQU) was another company that pushed the Consumer Durables industry lower today. Kewaunee Scientific was down $0.86 (4.7%) to $17.62 on heavy volume. Throughout the day, 21,723 shares of Kewaunee Scientific exchanged hands as compared to its average daily volume of 1,900 shares. The stock ranged in price between $16.65-$18.27 after having opened the day at $18.27 as compared to the previous trading day's close of $18.48.

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture products. The company operates through two segments, Domestic Operations and International Operations. Kewaunee Scientific has a market cap of $47.8 million and is part of the consumer goods sector. Shares are up 3.8% year-to-date as of the close of trading on Tuesday.

TheStreet Ratings rates Kewaunee Scientific as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Highlights from TheStreet Ratings analysis on KEQU go as follows:

  • The revenue growth came in higher than the industry average of 0.9%. Since the same quarter one year prior, revenues rose by 15.9%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • KEQU's debt-to-equity ratio is very low at 0.15 and is currently below that of the industry average, implying that there has been very successful management of debt levels. To add to this, KEQU has a quick ratio of 1.77, which demonstrates the ability of the company to cover short-term liquidity needs.
  • Compared to where it was a year ago today, the stock is now trading at a higher level, reflecting both the market's overall trend during that period and the fact that the company's earnings growth has been robust. Turning our attention to the future direction of the stock, it goes without saying that even the best stocks can fall in an overall down market. However, in any other environment, this stock still has good upside potential despite the fact that it has already risen in the past year.
  • KEWAUNEE SCIENTIFIC CORP reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. During the past fiscal year, KEWAUNEE SCIENTIFIC CORP increased its bottom line by earning $1.48 versus $1.17 in the prior year.
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income increased by 65.8% when compared to the same quarter one year prior, rising from $0.73 million to $1.20 million.

You can view the full analysis from the report here: Kewaunee Scientific Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.